We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT04613102
Brief Title: The Efficacy and Safety of 3% Cannabidiol (CBD) Cream in Patients With Epidermolysis Bullosa: A Phase II/III Trial

First Submitted : October 27, 2020
First Submitted that Met QC Criteria : October 27, 2020
First Posted : November 3, 2020

Last Update Submitted that Met QC Criteria : June 15, 2021
Last Update Posted : June 18, 2021